| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/11/2008 | US7342027 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/11/2008 | CA2340230C Pyridazinone derivatives having cell adhesion inhibiting activity |
| 03/11/2008 | CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 03/07/2008 | WO2008078424A1 Benzoxazole derivatives |
| 03/06/2008 | WO2008027932A2 Cytochrome p450 oxidase inhibitors and uses thereof |
| 03/06/2008 | WO2008027584A2 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase |
| 03/06/2008 | WO2008027539A1 Insecticidal n-substituted (2- sudstituted-1,3-thiazol) alkyl sulfoximines |
| 03/06/2008 | WO2008027521A1 Novel compositions and methods for treatment of diseases related to activated lymphocytes |
| 03/06/2008 | WO2008026769A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
| 03/06/2008 | WO2008026768A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/06/2008 | WO2008026046A1 Morpholine d3 dopamine antagonists |
| 03/06/2008 | WO2008025886A1 Metal chelates and chelating agents containing triazolyl subunits |
| 03/06/2008 | WO2007146225A3 Heterocyclic aspartyl protease inhibitors |
| 03/06/2008 | WO2007133622A3 Selective inhibitors of rock protein kinase and uses thereof |
| 03/06/2008 | US20080058519 Quinazoline ditosylate salt compounds |
| 03/06/2008 | US20080058515 indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity |
| 03/06/2008 | US20080058387 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 03/06/2008 | US20080058380 2-{[2-(3,5-difluorophenyl)acetyl]amino}-N-{5-[2-(isopropoxymethyl)phenyl]-1,3-thiazol-2-yl}propanamide; neuroprotectant; neurodegenerative diseases: Alzheimer's and Parkinson's disease, Down syndrome, amyloid angiopathy and cerebrovascular disorders |
| 03/06/2008 | US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent |
| 03/06/2008 | US20080058356 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists |
| 03/06/2008 | US20080058347 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058332 Antiproliferative, antitumor agents; 4-(3-hydroxyphenyl)-6-morpholino-2-(3-piperidin-4-ylcarbonylaminophenyl)pyrimidine for example |
| 03/06/2008 | US20080058320 Organic Compounds |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | US20080056991 Histamine H3 receptor inhibitors; (4-Azepan-1-ylmethyl-phenyl)-(4-isopropyl-piperazin-1-yl)-methanone dihydrochloride for example; allergies, nasal congestion, eating disorders, sleep disorders, neurodegenerative disorders |
| 03/06/2008 | CA2662215A1 Novel compositions and methods for treatment of diseases related to activated lymphocytes |
| 03/06/2008 | CA2662196A1 Inhibitors of phosphatidylinositol 3-kinase |
| 03/06/2008 | CA2661873A1 Cytochrome p450 oxidase inhibitors and uses thereof |
| 03/06/2008 | CA2661517A1 Insecticidal n-substituted (2-substituted-1,3-thiazol)alkyl sulfoximines |
| 03/06/2008 | CA2657469A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/05/2008 | EP1894930A1 Thiazole derivative |
| 03/05/2008 | EP1894929A1 Process for producing thiazolidinedione compound and production intermediate thereof |
| 03/05/2008 | EP1894920A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient |
| 03/05/2008 | EP1893609A1 N-(pyridin-2-yl)-sulfonamide derivatives |
| 03/05/2008 | EP1893608A2 Thiazolyl mglur5 antagonists and methods for their use |
| 03/05/2008 | EP1893606A2 Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/05/2008 | EP1893582A2 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| 03/05/2008 | EP1893581A1 Substituted arylpyrazoles for use against parasitites |
| 03/05/2008 | EP1893574A2 Peptide deformylase (pdf) inhibitors 4 |
| 03/05/2008 | EP1893573A1 Inhibitors of hcv replication |
| 03/05/2008 | EP1893572A2 Factor xa inhibitors |
| 03/05/2008 | EP1709036B1 Thiazole derivatives as a2b antagonists |
| 03/05/2008 | EP1633748B1 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/05/2008 | EP1575926B1 New pyridazin-3(2h)-one derivatives |
| 03/05/2008 | EP1560811B9 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/05/2008 | CN101137660A Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 03/05/2008 | CN101137653A Thiazole-4-carboxamide derivatives as MGLUR5 antagonists |
| 03/05/2008 | CN101137652A Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 03/05/2008 | CN101137651A 哒嗪酮化合物 Pyridazinone compound |
| 03/05/2008 | CN101137629A Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137628A Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137363A [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/05/2008 | CN101134756A Novel pharmaceutical |
| 03/05/2008 | CN100372844C 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 03/04/2008 | US7338976 Administering heterocyclic esters and amides: 3-phenyl-1-propyl(2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-(4-thiazolidine)carboxylate; 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; immunosuppressants; affinity for an FK binding protein-type immunophilin |
| 03/04/2008 | US7338968 inhibitors of IL-8 receptor binding; cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke, ischemia reperfusion injury, pain; novel antiinflammatory, antitumor agents |
| 03/04/2008 | US7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 03/04/2008 | US7338956 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/04/2008 | US7338950 Amide compounds as ion channel ligands and uses thereof |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 03/04/2008 | US7338720 Organic electroluminescent element |
| 02/28/2008 | WO2008024433A2 Haloalkyl-substituted pyrimidinone derivatives |
| 02/28/2008 | WO2008024390A2 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008023628A1 Compound having triazine ring structure substituted with pyridyl group and organic electroluminescent device |
| 02/28/2008 | WO2008023239A1 Pyrimidone compounds as gsk-3 inhibitors |
| 02/28/2008 | WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/28/2008 | WO2008022979A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 02/28/2008 | WO2008007123A3 Pharmaceutical compounds |
| 02/28/2008 | WO2007104034A3 Glucokinase activators |
| 02/28/2008 | WO2007017510A3 Isophthalic acid diamides for treating alzheimer's disease |
| 02/28/2008 | US20080051436 Use of Acylaminothiazole Derivatives as Therapeutic Agents |
| 02/28/2008 | US20080051418 Arylalkanoic Acid Derivative |
| 02/28/2008 | US20080051415 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 02/28/2008 | US20080051388 Novel Compounds That Inhibit Factor Xa Activity |
| 02/28/2008 | US20080050439 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/28/2008 | CA2661827A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 02/28/2008 | CA2661166A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 02/28/2008 | CA2661017A1 Organic compounds |
| 02/28/2008 | CA2657183A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 02/27/2008 | EP1892243A1 Polymorphic forms of ziprasidone sulphate salts |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
| 02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891063A2 Bicyclic derivatives as modulators of ion channels |
| 02/27/2008 | EP1891058A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 02/27/2008 | EP1891057A1 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators |
| 02/27/2008 | EP1891038A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators |
| 02/27/2008 | EP1890695A2 Use of 2,5-disubstituted thiazol-4-one derivatives in drugs |
| 02/27/2008 | EP1773810B1 New 4-benzylidene-piperidin derivatives |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |